original ) (raw )PROPIONYL- ? -CARNITINE AS POTENTIAL PROTECTIVE AGENT AGAINST ADRIAMYCIN-INDUCED IMPAIRMENT OF FATTY ACID BETA-OXIDATION IN ISOLATED HEART MITOCHONDRIA
Mohamed M Sayed-Ahmed
Pharmacological Research, 2000
View PDFchevron_right
Serum Lipid and Fatty Acid Profiles in Adriamycin-Treated Rats after Administration of L-Carnitine
Hye-ran Yoon
Pediatric Research, 2002
View PDFchevron_right
Fatty acid oxidation and related gene expression in heart depleted of carnitine by mildronate treatment in the rat
Pierre Clouet , Laurent Demizieux
Molecular and Cellular Biochemistry, 2000
View PDFchevron_right
Inhibition of gene expression of heart fatty acid binding protein and organic cation/carnitine transporter in doxorubicin cardiomyopathic rat model
Othman Shabanah , Mohamed M Sayed-Ahmed
European Journal of Pharmacology, 2010
View PDFchevron_right
Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions
Emilia Reda , Menotti Calvani
Basic Research in Cardiology, 2000
View PDFchevron_right
Propionyl- ? -Carnitine as protector against adriamycin-induced Cardiomyopathy
Mohamed M Sayed-Ahmed
Pharmacological Research, 2001
View PDFchevron_right
Propionyl l Carnitine as protector against adriamycin-induced Cardiomyopathy
Mohammed Sayed
Pharmacological Research, 2001
View PDFchevron_right
CARNITINE PALMITOYL TRANSFERASE‐I INHIBITION IS NOT ASSOCIATED WITH CARDIAC HYPERTROPHY IN RATS FED A HIGH‐FAT DIET
Paul Ernsberger
Clinical and …, 2007
View PDFchevron_right
Carnitine protection against adriamycin-induced cardiomyopathy in rats
Dennis Paulson
Life Sciences, 1986
View PDFchevron_right
Combined therapy with PPARα agonist and l-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency
Ryotaro Takahashi
Cardiovascular Research, 2006
View PDFchevron_right
A Moderate Carnitine Deficiency Exacerbates Isoproterenol-Induced Myocardial Injury in Rats
Pietro Lo Giudice
Cardiovascular Drugs and Therapy, 2016
View PDFchevron_right
Combined therapy with PPARa agonist and l-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency
Ryotaro Takahashi
2006
View PDFchevron_right
Carnitine Acetyltransferase is not a Cytosolic Enzyme in Rat Heart and Therefore Cannot Function in the Energy-linked Regulation of Cardiac Fatty Acid Oxidation
Horst Schulz
Journal of Molecular and Cellular Cardiology, 1998
View PDFchevron_right
Acetyl-l-carnitine supplementation reverses the age-related decline in carnitine palmitoyltransferase 1 (CPT1) activity in interfibrillar mitochondria without changing the l-carnitine content in the rat heart
Luis Castañeda Gomez
Mechanisms of Ageing and Development, 2012
View PDFchevron_right
Effects of some L-carnitine derivatives on heart membrane ATPases
Roberto Victor Ferrari
Cardiovascular Drugs and Therapy, 1991
View PDFchevron_right
Palmitoyl-carnitine increases RyR2 oxidation and sarcoplasmic reticulum Ca(2+) leak in cardiomyocytes: Role of adenine nucleotide translocase
J. Thireau
Biochimica et biophysica acta, 2015
View PDFchevron_right
Therapeutic Effects of l-Carnitine and Propionyl-l-carnitine on Cardiovascular Diseases: A Review
Claudio Ceconi
Annals of The New York Academy of Sciences, 2004
View PDFchevron_right
Carnitine homeostasis, mitochondrial function and cardiovascular disease
Shruti Sharma
Drug Discovery Today: Disease Mechanisms, 2009
View PDFchevron_right
Inhibition of Gene Expression of Carnitine Palmitoyltransferase I and Heart Fatty Acid Binding Protein in Cyclophosphamide and Ifosfamide-Induced Acute Cardiotoxic Rat Models
Othman Shabanah , Naif Al-harbi , Mohamed M Sayed-Ahmed
Cardiovascular toxicology
View PDFchevron_right
Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency
Ryotaro Takahashi
Cardiovascular Research, 2005
View PDFchevron_right
Propionyl-L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat
Dennis Paulson
Molecular and cellular biochemistry, 2000
View PDFchevron_right
Carnitine deficiency-induced cardiomyopathy
Dennis Paulson
Molecular and cellular biochemistry, 1998
View PDFchevron_right
Effects of propionyl-l-carnitine on isolated mitochondrial function in the reperfused diabetic rat heart
Dennis Paulson
Diabetes Research and Clinical Practice, 2001
View PDFchevron_right
Propionyl-l-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model
Othman Shabanah , Mohamed M Sayed-Ahmed
Pharmacological Research, 2006
View PDFchevron_right
L-Carnitine: An Antioxidant Remedy for the Survival of Cardiomyocytes under Hyperglycemic Condition
Ileana Terruzzi
Journal of Diabetes Research
View PDFchevron_right
Acute Liver Carnitine Palmitoyltransferase I Overexpression Recapitulates Reduced Palmitate Oxidation of Cardiac Hypertrophy
Lori Walker
Circulation Research, 2013
View PDFchevron_right
Inhibition of L-carnitine biosynthesis and transport by methyl-γ-butyrobetaine decreases fatty acid oxidation and protects against myocardial infarction
Ivars Kalvins
British journal of pharmacology, 2015
View PDFchevron_right
Differential Regulation of Carnitine Palmitoyltransferase-I Gene Isoforms (CPT-I α and CPT-Iβ ) in the Rat Heart
George Cook
Journal of Molecular and Cellular Cardiology, 2001
View PDFchevron_right
Heart dysfunction induced by choline-deficiency in adult rats: The protective role of l-carnitine
Charis Liapi
European Journal of Pharmacology, 2013
View PDFchevron_right